How can the Cunningham Panel help identify whether neurologic and psychiatric symptoms may be due to an underlying infection-triggered autoimmune encephalopathy?
Video Chapters:
2:56: Start of Presentation
4:31: Neuropsychiatric disorders diagnosed based on symptoms - not etiology
6:26: Study: Infections & risk for neuropsychiatric illnesses in children
9:09: Discovery of many neuronal autoantibodies
9:47: How does this occur biologically?
13:18: Study: OCD/tics in children & brain inflammation
16:02: Other immune-mediated disorders
16:54: Infections most frequently associated with neuropsychiatric symptoms
17:33: Molecular mimicry & autoimmunity
23:22: Commonalities in patients with positive Cunningham Panel results
25:36: Biomarkers in Cunningham Panel
28:59: Cunningham Panel case studies - before & after treatment
37:21: Goal of precision medicine
38:03: Ordering, testing & results process for the Cunningham Panel
39:04: Guidelines for diagnosis & treatment
40:26: Effective treatments
46:00: Q&A
46:18: What to do with borderline results?
48:41: Are there specific, contracted lab sites that the patient must use for blood draw?
50:20: Patient did not have acute onset but got progressively worse after COVID vaccination and infection. Impact of COVID on these patients?
53:11: Do medications, like Risperidone, effect test results since it blocks dopamine receptors?
55:09: Empiric trials of IVIG or plasmapheresis? If so, how would a patient access that?
56:46: Can Turmeric and Cannabis impact test results?
58:00: Can the Cunningham Panel be used for adult patients?
26 авг 2024
